0000000000866960

AUTHOR

Jens Jung

showing 1 related works from this author

Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: resu…

1999

Whether the safety and efficacy of implantable cardioverter defibrillator (ICD) therapy can be assured with lower output devices is an important question. The purpose of this study was to evaluate whether programming the device output at twice the augmented defibrillation threshold was as safe and effective as using the maximum energy. Patients indicated for ICD therapy, but without slow monomorphic ventricular tachycardia (MVT), who achieved an augmented defibrillation threshold (DFT plus)or = 15 joules (J) with a single endocardial lead system and a biphasic defibrillator were included in the study. Prior to ICD implantation, patients were randomized into 2 groups. The shock energies in t…

AdultMalemedicine.medical_specialtyDefibrillationTest groupmedicine.medical_treatmentImplantable defibrillatorDefibrillation thresholdElectrocardiographyLow energyInternal medicineMedicineHumansProspective StudiesAgedEjection fractionEquipment Safetybusiness.industryMiddle AgedImplantable cardioverter-defibrillatorDefibrillators ImplantableSurvival RateTreatment OutcomeShock (circulatory)Ventricular FibrillationCardiologyTachycardia VentricularFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessSoftwareThe American journal of cardiology
researchProduct